Correlation Between Pieris Pharmaceuticals and Revolution Medicines
Can any of the company-specific risk be diversified away by investing in both Pieris Pharmaceuticals and Revolution Medicines at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pieris Pharmaceuticals and Revolution Medicines into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pieris Pharmaceuticals and Revolution Medicines, you can compare the effects of market volatilities on Pieris Pharmaceuticals and Revolution Medicines and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pieris Pharmaceuticals with a short position of Revolution Medicines. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pieris Pharmaceuticals and Revolution Medicines.
Diversification Opportunities for Pieris Pharmaceuticals and Revolution Medicines
-0.5 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Pieris and Revolution is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding Pieris Pharmaceuticals and Revolution Medicines in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Revolution Medicines and Pieris Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pieris Pharmaceuticals are associated (or correlated) with Revolution Medicines. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Revolution Medicines has no effect on the direction of Pieris Pharmaceuticals i.e., Pieris Pharmaceuticals and Revolution Medicines go up and down completely randomly.
Pair Corralation between Pieris Pharmaceuticals and Revolution Medicines
Given the investment horizon of 90 days Pieris Pharmaceuticals is expected to under-perform the Revolution Medicines. But the stock apears to be less risky and, when comparing its historical volatility, Pieris Pharmaceuticals is 1.24 times less risky than Revolution Medicines. The stock trades about -0.01 of its potential returns per unit of risk. The Revolution Medicines is currently generating about 0.34 of returns per unit of risk over similar time horizon. If you would invest 4,775 in Revolution Medicines on August 28, 2024 and sell it today you would earn a total of 975.00 from holding Revolution Medicines or generate 20.42% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pieris Pharmaceuticals vs. Revolution Medicines
Performance |
| Timeline |
| Pieris Pharmaceuticals |
| Revolution Medicines |
Pieris Pharmaceuticals and Revolution Medicines Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pieris Pharmaceuticals and Revolution Medicines
The main advantage of trading using opposite Pieris Pharmaceuticals and Revolution Medicines positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pieris Pharmaceuticals position performs unexpectedly, Revolution Medicines can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Revolution Medicines will offset losses from the drop in Revolution Medicines' long position.| Pieris Pharmaceuticals vs. Adaptimmune Therapeutics Plc | Pieris Pharmaceuticals vs. Mereo BioPharma Group | Pieris Pharmaceuticals vs. PDS Biotechnology Corp | Pieris Pharmaceuticals vs. Leap Therapeutics |
| Revolution Medicines vs. Eliem Therapeutics | Revolution Medicines vs. HCW Biologics | Revolution Medicines vs. Scpharmaceuticals | Revolution Medicines vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |